Ramsay out, Macquarie in for global equity best ideas
Global financial group Macquarie Group has replaced Ramsay Health Care in the Morningstar Australia and New Zealand monthly Best Stock Ideas list on concerns about the private healthcare provider's long-term growth outlook.
Global financial group Macquarie Group has replaced Ramsay Health Care in the 
Morningstar Australia and New Zealand monthly Best Stock Ideas list on concerns about the private healthcare provider's long-term growth outlook.
While analysts continue to believe the RHC's (ASX: RHC) shares are undervalued, they have become increasingly worried about weaker long-term earnings growth because of challenging regulatory environments in Ramsay’s main markets in Australia, France, and the United Kingdom.
"We believe a larger margin of safety is now warranted," the authors of the November update wrote.
Additionally, they believe the eagerness with which the Ramsay acquired Swedish hospital operator Capio points to revenue growth challenges in other areas of the group.
Analysts also have growing concerns about the balance sheet.
"Although Ramsay’s balance sheet is in reasonable shape, it is vulnerable to a deterioration in earnings, given sizable operating lease obligations," the report said.
"Net debt was $3.2 billion at June 30 on a fully consolidated basis, which implies a reasonable net debt/EBITDA ratio of 2.3 and EBIT/interest coverage of 9. However, metrics look worse on a lease-adjusted basis, with net debt/EBITDAR of 3.8 and EBITR/interest plus rent of 2.3."
Analysts expect the Capio acquisition to increase fully consolidated net debt by $1.4 billion, which will stretch the net debt/EBITDA ratio to 3.2 and reduce the EBIT/interest coverage to 7.6.
Morningstar analysts recently cut their fair value estimate for narrow-moat-rated Ramsay Health Care by 14 per cent to $65 per share following a reduction in their long-term earnings growth forecasts and the transition of coverage to a new analyst.
However, at the current market price of $55.82, they continue to believe the shares are undervalued.
Ramsay Health Care's exit from the list made way for global diversified financial services firm Macquarie Group (ASX: MQG).
Analysts say diversification and interlinking of the five businesses -- Macquarie Asset Management, Macquarie Corporate Asset and Finance, Macquarie Banking and Financial Services, Macquarie Commodities and Global Markets, and Macquarie Capital, are key to the firm generating long-term revenue growth.
"The extent of interconnectivity among the five groups and operating leverage provides attractive earnings upside that we think the market underappreciates," the report said.
"We like the firm’s growth profile, longstanding senior management, long-term investment approach, and upside from exposure to infrastructure, energy, and technology sectors."
This month also marks the end of the tenure of Nicholas Moore as CEO of group, who will make way for company stalwart Shemara Wikramanayake.
Moore, who took over from Allan Moss in 2008, is credited with steering the bank through the GFC and beyond, during which time the share price was hovering below $16.
Analysts see the interconnectedness of Macquarie's adjacent businesses as a real competitive advantage and key to continued strong growth in shareholder returns.
Additionally, analysts see the group's status as a world-leading infrastructure fund manager with increasing exposure to renewable energy as beneficial long-term.
"[Macquarie] is in a good position to benefit from huge growth in global infrastructure and energy investment in the next decade.”
Morningstar analysts recently upgraded Macquarie Group's moat rating to narrow based on the competitive advantages of Macquarie's underlying businesses.
At 11am Sydney time, the stock was trading at $121.30, below Morningstar's $130 fair value estimate. On Friday, Macquarie's stock leapt about 3 per cent after the group signalled that its full year profit would be up about 10 per cent on financial-year 2018.
More from Morningstar
• Automotive Holdings undervalued despite property market ripple effect
• Make better investment decisions with Morningstar Premium | Free 4-week trial
Emma Rapaport is a reporter with Morningstar Australia, based in Sydney.
© 2018 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782 ("ASXO"). The article is current as at date of publication.
